UroGen Pharma Ltd. Increase (Decrease) in Inventories
UroGen Pharma Ltd. (URGN) reported Increase (Decrease) in Inventories of $8.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- UroGen Pharma Ltd. increase (decrease) in inventories for the quarter ending 2026-06-30 was $3.67M.
- UroGen Pharma Ltd. increase (decrease) in inventories for the quarter ending 2026-03-31 was $4.46M.
- UroGen Pharma Ltd. increase (decrease) in inventories for the quarter ending 2025-12-31 was $8.12M, a 397.43% increase year-over-year.
- UroGen Pharma Ltd. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.21M, a 698.03% increase year-over-year.
- UroGen Pharma Ltd. increase (decrease) in inventories for fiscal 2025 was $7.24M, a 103.63% increase from fiscal 2024.
- UroGen Pharma Ltd. increase (decrease) in inventories for fiscal 2024 was $3.55M, a 163.65% increase from fiscal 2023.
- UroGen Pharma Ltd. increase (decrease) in inventories for fiscal 2023 was $1.35M, a 272.38% increase from fiscal 2022.
- UroGen Pharma Ltd. increase (decrease) in inventories for fiscal 2022 was $362.00K, a 87.38% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.13M 10-Q · filed 2026-08-05 | $16.25M derived: sum of 3 quarters · filed 2026-08-05 | $17.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $4.46M 10-Q · filed 2026-05-06 | $12.58M derived: sum of 2 quarters · filed 2026-05-06 | $13.79M derived: sum of 3 quarters · filed 2026-05-06 | $13.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.34M derived: sum of 2 quarters · filed 2026-03-02 | $8.87M derived: sum of 3 quarters · filed 2026-08-05 | $7.24M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $751.00K derived: sum of 2 quarters · filed 2026-08-05 | -$886.00K 10-Q · filed 2025-11-06 | $747.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.10M 10-Q · filed 2026-08-05 | -$466.00K derived: sum of 3 quarters · filed 2026-08-05 | -$314.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.64M 10-Q · filed 2026-05-06 | -$4.00K derived: sum of 2 quarters · filed 2026-05-06 | $148.00K derived: sum of 3 quarters · filed 2026-05-06 | $347.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.78M derived: sum of 2 quarters · filed 2026-03-02 | $1.98M derived: sum of 3 quarters · filed 2026-03-02 | $3.55M 10-K · filed 2026-03-02 |
| 2024-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $351.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.92M 10-Q · filed 2025-11-06 | $2.59M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.77M 10-Q · filed 2025-08-07 | $2.44M derived: sum of 3 quarters · filed 2025-08-07 | $2.45M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.57M 10-Q · filed 2025-05-12 | $2.24M derived: sum of 2 quarters · filed 2025-05-12 | $2.25M derived: sum of 3 quarters · filed 2025-05-12 | $1.78M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $685.00K derived: sum of 2 quarters · filed 2025-03-10 | $208.00K derived: sum of 3 quarters · filed 2025-03-10 | $1.35M 10-K · filed 2025-03-10 |
| 2023-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$463.00K derived: sum of 2 quarters · filed 2024-11-06 | $677.00K 10-Q · filed 2024-11-06 | $394.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $663.00K 10-Q · filed 2024-08-13 | $380.00K derived: sum of 3 quarters · filed 2024-08-13 | $545.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.14M 10-Q · filed 2024-05-13 | $857.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.02M derived: sum of 3 quarters · filed 2024-05-13 | $1.58M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$118.00K derived: sum of 2 quarters · filed 2024-03-14 | $438.00K derived: sum of 3 quarters · filed 2024-03-14 | $362.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $721.00K derived: sum of 2 quarters · filed 2023-11-14 | $645.00K 10-Q · filed 2023-11-14 | $1.67M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $480.00K 10-Q · filed 2023-08-10 | $1.50M derived: sum of 3 quarters · filed 2023-08-10 | $1.89M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$76.00K 10-Q · filed 2023-05-11 | $948.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.33M derived: sum of 3 quarters · filed 2023-05-11 | $1.43M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.41M derived: sum of 2 quarters · filed 2023-03-24 | $1.50M derived: sum of 3 quarters · filed 2023-03-24 | $2.87M 10-K · filed 2023-03-24 |
| 2021-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $477.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.84M 10-Q · filed 2022-11-10 | $2.46M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.46M 10-Q · filed 2022-08-11 | $2.08M derived: sum of 3 quarters · filed 2022-08-11 | $2.30M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.37M 10-Q · filed 2022-05-10 | $1.99M derived: sum of 2 quarters · filed 2022-05-10 | $2.21M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $839.00K derived: sum of 2 quarters · filed 2022-03-21 | $1.96M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.35M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $1.13M 10-Q · filed 2021-08-04 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$142.00K derived: sum of 2 quarters · filed 2020-03-02 | -$349.00K derived: sum of 3 quarters · filed 2020-03-02 | -$316.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | -$142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$349.00K derived: sum of 2 quarters · filed 2019-11-12 | -$316.00K 10-Q · filed 2019-11-12 | -$137.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$174.00K 10-Q · filed 2019-08-09 | $5.00K derived: sum of 3 quarters · filed 2020-03-02 | -$256.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $33.00K 10-Q · filed 2019-05-09 | $212.00K derived: sum of 2 quarters · filed 2020-03-02 | -$49.00K derived: sum of 3 quarters · filed 2020-03-02 | $118.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $179.00K derived: 10-K 12 month − 6-K 9 month · filed 2020-03-02 | -$82.00K derived: sum of 2 quarters · filed 2020-03-02 | $85.00K derived: sum of 3 quarters · filed 2020-03-02 | $211.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$261.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | -$94.00K derived: sum of 2 quarters · filed 2018-11-13 | $32.00K 6-K · filed 2018-11-13 | |
| 2017-06-30 | $167.00K derived: 6-K 6 month − 6-K 3 month · filed 2018-08-14 | $293.00K 6-K · filed 2018-08-14 | ||
| 2017-03-31 | $126.00K 6-K · filed 2018-05-15 | |||
| 2016-12-31 | $105.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |